| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/12/2001 | EP1131063A2 Hyperforin as cytostatic agent and hyperforin ointment or cream as application form |
| 09/12/2001 | EP1131062A1 Injectable propofol formulations |
| 09/12/2001 | EP1131059A1 Dry powder for inhalation |
| 09/12/2001 | EP1131057A1 Cushioning wax beads for making solid shaped articles |
| 09/12/2001 | EP1131056A1 Particles based on polyamino-acid(s) and methods for preparing same |
| 09/12/2001 | EP1131055A1 Treatment set containing lungsurfactant compositions |
| 09/12/2001 | EP1131054A2 Methods for preparing coated drug particles and pharmaceutical formulations thereof |
| 09/12/2001 | EP1131053A2 Nanocapsules and method of production thereof |
| 09/12/2001 | EP1131052A1 Vaginally administrable progesterone-containing tablets and method for preparing same |
| 09/12/2001 | EP1131051A1 Pressurised metered dose inhalers (mdi) |
| 09/12/2001 | EP1131050A1 Galenic formulations fast disintegrating in the mouth and method for preparing same |
| 09/12/2001 | EP1131047A1 Oil bodies as topical delivery vehicles for active agents |
| 09/12/2001 | EP1131037A1 Process for the manufacture of liquid filled capsules |
| 09/12/2001 | EP1130966A1 Antiparasitic formulations |
| 09/12/2001 | EP1130964A1 Therapeutic anti-fungal nail preparation |
| 09/12/2001 | EP0847268B1 Refreshing compositions |
| 09/12/2001 | EP0788349B1 Liposome composition containing selegilin |
| 09/12/2001 | EP0782855B1 Nimesulide for external use |
| 09/12/2001 | CN1312857A A polypeptide polymer conjugate |
| 09/12/2001 | CN1312796A 5-thia-omega-substituted phenyl-prostaglandin E derivatives, process for producing same and drugs containing same as active ingredient |
| 09/12/2001 | CN1312722A Compounds obtained from i(salvia) species having antiviral activity |
| 09/12/2001 | CN1312714A Pharmaceutical composition containing lipase inhibitors and chitosan |
| 09/12/2001 | CN1312713A Pharmaceutical compositions containing lipase inhibitors |
| 09/12/2001 | CN1312708A Process of generating submicron particles of water-insuluble compounds |
| 09/12/2001 | CN1312707A Method of forming liposomes |
| 09/12/2001 | CN1312706A Medicinal aerosol for mulations |
| 09/12/2001 | CN1312080A Composition containing fatty acid |
| 09/12/2001 | CN1070853C 10-acyloxy-10,11-dihydrodibenz/b,f/azepine-5-carboxamides useful for treating nervous system disorders |
| 09/12/2001 | CN1070704C Calcium-modified oxidized cellulose homostat |
| 09/12/2001 | CN1070699C Topical composition comprising N-acetye-L-cysteine |
| 09/11/2001 | US6288234 Fluorinated heterocyclic amido amine compounds as drugs |
| 09/11/2001 | US6288222 Hydrolyzing lactose to glucose and galactose; isolating sialyloligosaccharide; purification; cosmetics, food, infant formula, drugs |
| 09/11/2001 | US6288127 Adding lewis acid inhibitor |
| 09/11/2001 | US6288107 Sulfatase inhibitors |
| 09/11/2001 | US6288080 High speed absorption in blood; nonprecipitating |
| 09/11/2001 | US6288076 Antimicrobial compositions |
| 09/11/2001 | US6288055 Analgesic agents |
| 09/11/2001 | US6288047 Lipid-based immune modulator composition |
| 09/11/2001 | US6288043 Injectable hyaluronate-sulfated polysaccharide conjugates |
| 09/11/2001 | US6288040 Medicament excipient particles for tissue-specific application of a medicament |
| 09/11/2001 | US6288034 Administering antiproliferative agent to treat autoimmune diseases |
| 09/11/2001 | US6288026 Administering a paravac composition as a parenteral adjuvant for reduced side effects |
| 09/11/2001 | US6288025 Protease inhibitors for use in the treatment of psoriasis |
| 09/11/2001 | US6287857 Nucleic acid delivery vehicles |
| 09/11/2001 | US6287817 Administering fusion protein of single chain fv molecule against transcytotic receptor linked to therapeutic protein; delivers protein to epithelial cell; treatment of cystic fibrosis |
| 09/11/2001 | US6287792 Drug delivery of antisense oligonucleotides and peptides to tissues in vivo and to cells using avidin-biotin technology |
| 09/11/2001 | US6287615 Use of solubilized carotenoid preparations for coloring food preparations |
| 09/11/2001 | US6287604 Biodegradable targetable microparticle delivery system |
| 09/11/2001 | US6287603 Cyclodextrin flavor delivery systems |
| 09/11/2001 | US6287602 Treatment of oncologic tumors with an injectable formulation of a Golgi apparatus disturbing agent |
| 09/11/2001 | US6287601 Equine laminitis |
| 09/11/2001 | US6287599 Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles |
| 09/11/2001 | US6287596 Drug delivery |
| 09/11/2001 | US6287594 Oral liquid compositions |
| 09/11/2001 | US6287593 Anticancer |
| 09/11/2001 | US6287592 Aqueous drink composition comprising ibuprofen |
| 09/11/2001 | US6287591 Stable for theraputic use, hiv, cytomegalo virus, antiinflammatory, antitumor |
| 09/11/2001 | US6287590 Peptide/lipid complex formation by co-lyophilization |
| 09/11/2001 | US6287588 Agent delivering system comprised of microparticle and biodegradable gel with an improved releasing profile and methods of use thereof |
| 09/11/2001 | US6287579 Oxidatively stable long-chain ethyl ester emollients |
| 09/11/2001 | US6287568 Forming antibodies |
| 09/11/2001 | US6287562 Methods of inhibiting the growth of cells bearing LewisY antigens using B1, B3, or B5 targeted immunoconjugates |
| 09/11/2001 | US6287551 Method for treating herpes virus |
| 09/11/2001 | US6287536 Two-step pretargeting methods using improved bidtin-active agent conjugates |
| 09/11/2001 | CA2195119C Formulations and methods for providing prolonged local anesthesia |
| 09/11/2001 | CA2020368C Angiographic adjuvant |
| 09/10/2001 | CA2339705A1 Inhibiting oxidative degradation of pharmaceutical formulations |
| 09/07/2001 | WO2001064930A1 Protein hollow nano particles, transporter with the use of the same and method of introducing substance into cells |
| 09/07/2001 | WO2001064743A1 GPib-LIPID BOND CONSTRUCT AND USE THEREOF |
| 09/07/2001 | WO2001064738A2 Heparin-binding amino acid sequences derived from human proteins facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 09/07/2001 | WO2001064690A1 Gastro-specific prodrugs |
| 09/07/2001 | WO2001064650A2 Synthesis of epothilones, intermediates thereto and analogues thereof |
| 09/07/2001 | WO2001064633A1 Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof |
| 09/07/2001 | WO2001064605A2 Generation and screening of a dynamic combinatorial library |
| 09/07/2001 | WO2001064330A1 Nanocapsules having a polyelectrolyte envelope |
| 09/07/2001 | WO2001064328A1 Lipid nanocapsules, preparation method and use as medicine |
| 09/07/2001 | WO2001064258A1 Agent for the treatment of wounds |
| 09/07/2001 | WO2001064255A1 Method for detecting and killing epithelial cancer cells |
| 09/07/2001 | WO2001064254A2 Engineered spray-dried lipid-based microparticles for cellular targeting |
| 09/07/2001 | WO2001064253A1 P-glycoprotein modifier-containing medicinal compositions to be delivered to the large intestine |
| 09/07/2001 | WO2001064245A1 Immune enhancement compositions and use thereof |
| 09/07/2001 | WO2001064241A1 Preparations stabilized over long time |
| 09/07/2001 | WO2001064236A2 METHODS FOR TREATING FSH RELATED CONDITIONS WITH GnRH ANTAGONISTS |
| 09/07/2001 | WO2001064225A1 Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response |
| 09/07/2001 | WO2001064222A1 Veterinary compositions for the treatment of parasitic diseases |
| 09/07/2001 | WO2001064221A1 Low dose entecavir formulation and use |
| 09/07/2001 | WO2001064214A2 Compositions and methods for the treatment of inflammatory diseases using topoisomerase inhibitors |
| 09/07/2001 | WO2001064189A1 Coated granules and foaming compositions containing the same |
| 09/07/2001 | WO2001064188A1 Therapeutic compositions for pulmonary delivery |
| 09/07/2001 | WO2001064187A2 Anaesthetic formulations |
| 09/07/2001 | WO2001064186A1 Urogenital or anorectal transmucosal vaccine delivery system |
| 09/07/2001 | WO2001064185A2 Method for making, loading and sealing a cell or drug encapsulation device, and such a device |
| 09/07/2001 | WO2001064184A1 Percutaneous administration preparations |
| 09/07/2001 | WO2001064183A1 Orally administered controlled delivery system for once daily administration of ciprofloxacin |
| 09/07/2001 | WO2001064182A2 Improvements in or relating to the delivery of oral drugs |
| 09/07/2001 | WO2001064164A2 Nanocapsule encapsulation system and method |
| 09/07/2001 | WO2001064163A2 An improved herbal composition having antiallergic properties and a process for the preparation thereof |
| 09/07/2001 | WO2001064110A1 Method for detecting and killing epithelial cancer cells |
| 09/07/2001 | WO2001064057A1 Novel pharmaceutical or dietetic mushroom-based compositions |
| 09/07/2001 | WO2001064034A1 Antimicrobial sanitizing lotion with skin protection properties |